| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |